ArticleCurrent oncology (Toronto, Ont.)2022

Biomarker Discordances and Alterations Observed in Breast Cancer Treated with Neoadjuvant Chemotherapy: Causes, Frequencies, and Clinical Significances.

Cengiz Yilmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.